Skip to content

Acute Toxicity Related to 25G-NBOMe Use: An Internet High.

Chloe Brooks, Alexander R Gibson, John Miell

Journal of acute medicine March 1, 2017 DOI: 10.6705/j.jacme.2017.0701.007 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population 17-year-old male who ingested 25G-NBOMe
Intervention 25G-NBOMe
Measures Glasgow Coma Scale (GCS), creatine kinase
Keywords Nbome Acute kidney injury Drug misuse
Key findings The authors report that a 17-year-old male who ingested 25G-NBOMe developed seizures, tachycardia, hypotension, hyperthermia, a persistently low Glasgow Coma Scale, metabolic derangement, elevated creatine kinase, and transient acute kidney injury requiring intensive care, while a friend who took the same drug had no adverse effects. They conclude that 25G-NBOMe can cause acute, potentially life-threatening toxicity.

Abstract

The NBOMe series is an emerging class of synthetic hallucinogens with limited data available on their use and effects. Whilst toxicity to related substances exist in the literature, no such cases exist for 25G-NBOMe. This case describes a 17-year old male who presented to the Emergency Department with seizures having ingested 25G-NBOMe that had been purchased over the Internet. He was tachycardic, hypotensive and hyperthermic on arrival and required admission to the Intensive Care Unit (ICU) due a persistently low Glasgow Coma Scale (GCS) and profound metabolic derangement. His inpatient stay was prolonged by a persistently high creatine kinase with associated transient acute kidney injury. In contrast, an accompanying friend who had ingested the same drug developed no adverse effects. Our patient's clinical presentation was consistent with reports of adverse outcomes associated with other drugs in the series and demonstrates that acute toxicity can also be seen with 25G-NBOMe with potentially life threatening outcomes.

Citations in the library